Cargando…

Analysis of COVID-19 convalescent plasma for SARS-CoV-2 IgG using two commercial immunoassays

Coronavirus Disease 2019 (COVID-19) convalescent plasma (CCP) was approved by the FDA for use in severe cases of COVID-19 under an emergency Investigational New Drug (IND) protocol. Eligibility criteria for CCP donors includes documentation of evidence of COVID-19 either by viral RNA detection at th...

Descripción completa

Detalles Bibliográficos
Autores principales:	DomBourian, Melkon G., Annen, Kyle, Huey, Leah, Andersen, Gillian, Merkel, Patricia A., Jung, Sarah, Dominguez, Samuel R., Knight, Vijaya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438987/ https://www.ncbi.nlm.nih.gov/pubmed/32828791 http://dx.doi.org/10.1016/j.jim.2020.112837

Ejemplares similares

Evaluation of a multiplexed coronavirus antigen array for detection of SARS-CoV-2 specific IgG in COVID-19 convalescent plasma
por: Huey, Leah, et al.
Publicado: (2021)

A New SARS-CoV-2 Dual-Purpose Serology Test: Highly Accurate Infection Tracing and Neutralizing Antibody Response Detection
por: Taylor, Sean C., et al.
Publicado: (2021)

Evaluation of the SARS-CoV-2-IgG response in outpatients by five commercial immunoassays
por: Wellinghausen, Nele, et al.
Publicado: (2020)

Diagnostic performance of commercial IgM and IgG enzyme-linked immunoassays (ELISAs) for diagnosis of Zika virus infection
por: Kikuti, Mariana, et al.
Publicado: (2018)

Immunoassay for quantification of antigen-specific IgG fucosylation
por: Šuštić, Tonći, et al.
Publicado: (2022)

Multiplex Microsphere Immunoassays for the Detection of IgM and IgG to Arboviral Diseases
por: Basile, Alison J., et al.
Publicado: (2013)

Validation of dried blood spot sample modifications to two commercially available COVID-19 IgG antibody immunoassays
por: Zava, Theodore T, et al.
Publicado: (2020)

Evaluation of Four Commercial IgG- and IgM-specific Enzyme Immunoassays for Detecting Mycoplasma pneumoniae Antibody: Comparison with Particle Agglutination Assay
por: Yoo, Soo Jin, et al.
Publicado: (2007)

Long-Term Longitudinal Evaluation of Six Commercial Immunoassays for the Detection of IgM and IgG Antibodies against SARS CoV-2
por: Nedelcu, Iulia, et al.
Publicado: (2021)

Evaluation of a New Spike (S)-Protein-Based Commercial Immunoassay for the Detection of Anti-SARS-CoV-2 IgG
por: Eberhardt, Kirsten Alexandra, et al.
Publicado: (2021)

Neutralization of SARS-CoV-2 with IgG from COVID-19-convalescent plasma
por: Maeda, Kenji, et al.
Publicado: (2021)

IgG3 and IgM Identified as Key to SARS-CoV-2 Neutralization in Convalescent Plasma Pools
por: Kober, Christina, et al.
Publicado: (2022)

Preliminary multiplex microarray IgG immunoassay for the diagnosis of toxoplasmosis and rubella
por: Baschirotto, Priscila T, et al.
Publicado: (2017)

Analysis of the IgG subclass profile and IgG sum-total discrepancy in COVID-19 convalescent plasma donors: A single-centre prospective cohort study
por: Wasiluk, Tomasz, et al.
Publicado: (2023)

Validation of a Point‐of‐Care Quantitative Equine IgG Turbidimetric Immunoassay and Comparison of IgG Concentrations Measured with Radial Immunodiffusion and a Point‐of‐Care IgG ELISA
por: Ujvari, S., et al.
Publicado: (2017)

Clinical Evaluation of Antiphospholipase A2 Receptor IgG4 level and Its IgG4-to-IgG Ratio Based on Quantitative Immunoassays in Idiopathic Membranous Nephropathy
por: Zhang, Yi, et al.
Publicado: (2022)

Circulating IgG Levels in SARS-CoV-2 Convalescent Individuals in Cyprus
por: Mamais, Ioannis, et al.
Publicado: (2021)

Kinetics of anti-nucleocapsid IgG response in COVID-19 immunocompetent convalescent patients
por: Movsisyan, Mariam, et al.
Publicado: (2022)

The β-NGF/TrkA Signalling Pathway Is Associated With the Production of Anti-Nucleoprotein IgG in Convalescent COVID-19
por: Usai, Carla, et al.
Publicado: (2022)

Serological Detection of SARS-CoV-2 IgG Using Commercially Available Enzyme Immunoassays on Dried Blood Spots Collected from Patients
por: Walker, Gregory J., et al.
Publicado: (2021)

Enzyme-linked immunoassay for dengue virus IgM and IgG antibodies in serum and filter paper blood
por: Tran, Thanh Nga T, et al.
Publicado: (2006)

Anti-SARS-CoV-2 IgG and IgA antibodies in COVID-19 convalescent plasma do not enhance viral infection
por: Clark, Natasha M., et al.
Publicado: (2022)

Comparison of enzyme-linked immunosorbent assay and Fassisi(®) bovine immunoglobulin G (IgG) immunoassay for quantification of bovine IgG in neonatal calf serum
por: Hampe, Marian, et al.
Publicado: (2021)

SARS-CoV-2 IgG Antibody and its Clinical Correlates in Convalescent Plasma Donors: An Indian Experience
por: Kumar, PVSN Kiran, et al.
Publicado: (2021)

Associations Between Symptoms, Donor Characteristics and IgG Antibody Response in 2082 COVID-19 Convalescent Plasma Donors
por: Vinkenoog, Marieke, et al.
Publicado: (2022)

Preserved SARS-CoV-2 neutralizing IgG activity of in-house manufactured COVID-19 convalescent plasma
por: Inada, Makoto, et al.
Publicado: (2023)

Neutralization activity of IgG antibody in COVID‑19‑convalescent plasma against SARS-CoV-2 variants
por: Tsuchiya, Kiyoto, et al.
Publicado: (2023)

The real life performance of 7 automated anti-SARS-CoV-2 IgG and IgM/IgA immunoassays
por: Swadźba, Jakub, et al.
Publicado: (2021)

Diagnostic accuracy of an in-house Scrub Typhus enzyme linked immunoassay for the detection of IgM and IgG antibodies in Laos
por: Elders, Philip N. D., et al.
Publicado: (2020)

Development and validation of an enzyme immunoassay for detection and quantification of SARS-CoV-2 salivary IgA and IgG
por: Costantini, Veronica P., et al.
Publicado: (2021)

Comparison of diagnostic efficiency of detecting IgG and IgE with immunoassay method in diagnosing ABPA: a meta-analysis
por: Liu, Anlin, et al.
Publicado: (2023)

Enzyme immunoassays (EIA) for serodiagnosis of human leptospirosis: specific IgG3/IgG1 isotyping may further inform diagnosis of acute disease
por: Fortes-Gabriel, Elsa, et al.
Publicado: (2022)

Performance evaluation of two SARS-CoV-2 IgG/IgM rapid tests (Covid-Presto and NG-Test) and one IgG automated immunoassay (Abbott)
por: Charpentier, Charlotte, et al.
Publicado: (2020)

Evaluation of four laboratory-based SARS-CoV-2 IgG antibody immunoassays
por: Tanis, Jorg, et al.
Publicado: (2021)

SARS-CoV-2 IgG Levels Allow Predicting the Optimal Time Span of Convalescent Plasma Donor Suitability
por: Laner-Plamberger, Sandra, et al.
Publicado: (2022)

Rapid and quantitative detection of SARS-CoV-2 specific IgG for convalescent serum evaluation
por: Tan, Xiaotian, et al.
Publicado: (2020)

Comparison of five commercial anti-SARS-CoV-2 total antibodies and IgG immunoassays after vaccination with BNT162b2 mRNA
por: Danese, Elisa, et al.
Publicado: (2021)

A novel multiplex electrochemiluminescent immunoassay for detection and quantification of anti-SARS-CoV-2 IgG and anti-seasonal endemic human coronavirus IgG
por: Li, Fang Fang, et al.
Publicado: (2022)

Lower Levels of ABO Anti-A and Anti-B of IgM, IgG and IgA Isotypes in the Serum but Not the Saliva of COVID-19 Convalescents
por: Matzhold, Eva M., et al.
Publicado: (2022)

Assessment of SARS-CoV-2 IgG and IgM antibody detection with a lateral flow immunoassay test
por: Diani, Erica, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0vs8s27vo7f8meu646ru13n6dg